Clinical Trial

Orthobiological Therapies in Musculoskeletal Disorders

Study acronym: PROREGEN
Not Yet Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
To evaluate the clinical and functional effects of using orthobiological therapies (hyaluronic acid, platelet-rich plasma, bone marrow aspirate, nanofat, among others) in the treatment of various musculoskeletal diseases in patients routinely treated at the Proregen Medical Clinic and its affiliates. The sample will consist of adult patients (≥18 years), of both sexes, with different musculoskeletal diagnoses involving joints, tendons, ligaments, cartilage or bone, among others.
Trial Details
NCT Number NCT07434115
Lead Sponsor PROREGEN
Collaborators: Centro Universitário Univates
Conditions Musculoskeletal Diseases or Conditions
Enrollment 300 participants
Start Date 2026-01-30
Primary Completion 2029-01 (estimated)
Study Completion 2030-01 (estimated)
Updated on ClinicalTrials.gov 2026-02-25